mTORC2 Regulates Amino Acid Metabolism in Cancer by Phosphorylation of the Cystine-Glutamate Antiporter xCT.

about

Molecular and Genetic Determinants of Glioma Cell Invasion.Oncogenic PI3K promotes methionine dependency in breast cancer cells through the cystine-glutamate antiporter xCT.DNA Damage, Repair, and Cancer Metabolism.

P2860

Q46594099-707DC8D5-F830-4EA3-BE2B-A184A863CB88 Q48091849-58071083-2B55-49D1-9F46-6EEBE7B9F95F Q49829014-A9BAA78C-0C0F-49CA-9ED7-3BAF21DDA4F7

P2860

mTORC2 Regulates Amino Acid Metabolism in Cancer by Phosphorylation of the Cystine-Glutamate Antiporter xCT.

Item

http://www.wikidata.org/entity/Q46197917

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

mTORC2 Regulates Amino Acid Me ...... tine-Glutamate Antiporter xCT.

@en

mTORC2 Regulates Amino Acid Me ...... tine-Glutamate Antiporter xCT.

@nl

type

Item

label

mTORC2 Regulates Amino Acid Me ...... tine-Glutamate Antiporter xCT.

@en

mTORC2 Regulates Amino Acid Me ...... tine-Glutamate Antiporter xCT.

@nl

prefLabel

mTORC2 Regulates Amino Acid Me ...... tine-Glutamate Antiporter xCT.

@en

mTORC2 Regulates Amino Acid Me ...... tine-Glutamate Antiporter xCT.

@nl

P1476

mTORC2 Regulates Amino Acid Me ...... stine-Glutamate Antiporter xCT

@en

P2093

Andrew K Shiau

http://www.w3.org/2001/XMLSchema#string

Beatrice Gini

http://www.w3.org/2001/XMLSchema#string

Claudio P Albuquerque

http://www.w3.org/2001/XMLSchema#string

Daniel Braas

http://www.w3.org/2001/XMLSchema#string

Genaro R Villa

http://www.w3.org/2001/XMLSchema#string

Heather R Christofk

http://www.w3.org/2001/XMLSchema#string

Huijun Yang

http://www.w3.org/2001/XMLSchema#string

Junfeng Bi

http://www.w3.org/2001/XMLSchema#string

Kenta Masui

http://www.w3.org/2001/XMLSchema#string

Kun-Liang Guan

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth

Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton

mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery

Discovery of 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one as a highly potent, selective mammalian target of rapamycin (mTOR) inhibitor for the treatment of cancer

mTOR signaling in growth control and disease

Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1

Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis

SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma

P304

128-138.e7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.MOLCEL.2017.05.030

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Huilin Zhou

P577

2017-06-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28648777

http://www.w3.org/2001/XMLSchema#string

P921

phosphorylation

P932

5521991

http://www.w3.org/2001/XMLSchema#string

mTORC2 Regulates Amino Acid Metabolism in Cancer by Phosphorylation of the Cystine-Glutamate Antiporter xCT.

about

P2860

P2860

mTORC2 Regulates Amino Acid Metabolism in Cancer by Phosphorylation of the Cystine-Glutamate Antiporter xCT.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932